Teva Gets FDA Approval for Generic Norvasc
Posted on: Tuesday, 3 July 2007, 21:17 CDT
Teva Pharmaceutical Industries has been granted FDA approval for its amlodipine besylate tablets for the treatment of chronic stable angina and vasospastic angina.
The approval covers the drug in 2.5mg, 5mg and 10mg doses. Shipment of the product will begin shortly.
Teva's tablets are the AB-rated generic equivalent of Pfizer's Norvasc tablets. Mylan, which also markets a generic version, has sued the FDA arguing that its 180-day exclusivity blocks other final approvals until September, 2007.
Total annual sales of the drug are approximately $2.8 billion for the 12 months ended March 31, 2007, based on IMS sales data.
Source: Datamonitor
Related Articles
- Austin, Texas, Companies Hope to Become Leaders in Growing Tablet PC Niche
- Tablet PC to speak more languages
- Microsoft Extends Multilanguage Support for the Tablet PC
- Fujitsu Offers New Twist On Tablet Computing
- Transmeta's Energy Efficient Processor in First Sub-$1000 Tablet PC
- (COR.TO) Corel Grafigo Wins 'Best of Show' Award; Industry Acclaim and Extensive User Up-Take Support Tablet PC Graphics Tool
- GiveMePower Ships New PowerCAD Pro For Windows Desktop, Laptop And XP Tablet PCs
- Leszynski Group Launches Training Products for Tablet PC Solution Developers
- NEC Versa LitePad Tablet PC Wins 2003 World Class Award from PC World
- Itronix's tablet PC gets rugged
Rating: 3.2 / 5 (5 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds